Alibaba
BABA
NVIDIA
NVDA
Cisco
CSCO
Netflix
NFLX
Apple
AAPL
US Stock MarketDetailed Quotes
BIOA BioAge Labs
- 4.790
- +0.270+5.97%
Close Feb 14 16:00 ET
- 4.820
- +0.030+0.63%
Post 20:01 ET
171.72MMarket Cap-2.31P/E (TTM)
4.800High4.530Low116.42KVolume4.530Open4.520Pre Close547.72KTurnover1.11%Turnover RatioLossP/E (Static)35.85MShares26.62052wk High0.55P/B50.30MFloat Cap3.85052wk Low--Dividend TTM10.50MShs Float26.620Historical High--Div YieldTTM5.97%Amplitude3.850Historical Low4.704Avg Price1Lot Size
BioAge Labs Stock Forum
Sign in to post a comment
The attention of AI Medteck stocks are rapidly increasing.
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...
104
11
248
$BioAge Labs (BIOA.US)$ no volume
$BioAge Labs (BIOA.US)$ this one dead
$BioAge Labs (BIOA.US)$ Dead. No more hope
$BioAge Labs (BIOA.US)$
BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform Programs
Tuesday, 28th January at 9:00 am
Advancement of next-generation APJ agonists with discontinuation of azelaprag
Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial Ph1 clinical data anticipated by end of 2025
Expansion of discovery efforts based on insights from BioAge's platform, including a target identification collaboration with Novartis and a newly announced antibo...
BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform Programs
Tuesday, 28th January at 9:00 am
Advancement of next-generation APJ agonists with discontinuation of azelaprag
Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial Ph1 clinical data anticipated by end of 2025
Expansion of discovery efforts based on insights from BioAge's platform, including a target identification collaboration with Novartis and a newly announced antibo...
2
1
$BioAge Labs (BIOA.US)$ this stock is dead
$BioAge Labs (BIOA.US)$ No volume
$BioAge Labs (BIOA.US)$ institution is accumulating so just be patience
1
$BioAge Labs (BIOA.US)$ super slow and no volume
$BioAge Labs (BIOA.US)$ enough playing run the news
No comment yet
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Buy n Die Together❤ :
73610841 : Adrian Nathaniel carter, I can’t tag him and we’re Facebook friends, does anyone know why?
Seth Beaty : Though you know if you bet against Cathie Wood, you’ll probably make money.
Rob banks : is there an ETF for this ai medical sector?
Chak : is it goid time yo
get into TEM ?
View more comments...